Increased expression of cystine/glutamate antiporter in multiple sclerosis
about
Redox control of microglial function: molecular mechanisms and functional significanceBiomarkers in Multiple Sclerosis: An Up-to-Date OverviewHigh-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma CellsGinkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trialEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Pathogenic implications of iron accumulation in multiple sclerosis.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Change of cystine/glutamate antiporter expression in ethanol-dependent rats.Redox-based therapeutics in neurodegenerative disease.Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosisThiol redox homeostasis in neurodegenerative diseaseInhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory DemyelinationNatural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.Roles of white matter in central nervous system pathophysiologies.Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisAlcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats.PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.Oxidative stress and cancer pain.Classical and unconventional pathways of vesicular release in microglia.Neurotransmitter signaling in the pathophysiology of microglia.The role of glutamate and its receptors in multiple sclerosis.Neurotransmitter signaling in white matter.Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed.Development of a primary microglia screening assay and its use to characterize inhibition of system xc- by erastin and its analogs.Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages.Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damageP2X4 receptors control the fate and survival of activated microglia.Cystine/glutamate antiporter blockage induces myelin degeneration.In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.[18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis.Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling CascadeClonal Glial Response in a Multiple Sclerosis Mouse Model
P2860
Q27000279-78637163-6A9D-448E-BB66-E0EF04557CF0Q27496017-E232E315-FD19-4C25-8E52-AE9F3B7BF03DQ28547125-9D55D774-6090-4260-8387-048EE666C2E2Q30524879-3E3652AA-A856-46E5-88FF-A595E903FDD4Q33761211-CE6C1895-4916-453F-B001-8442FD036904Q34049616-D557BEE4-A4C6-4E6A-B64A-8E80E1F05B1FQ34279067-473C009E-9F04-4441-A15E-CD261FF1444BQ34292046-0773184A-15D2-454C-8970-2EA9945D9069Q34535918-830B2FA2-9324-4ACA-8ADE-8C9AA2D77815Q34807095-A4BC864D-8A02-40F2-9F0D-DA7541D4FEE9Q35614227-61480298-F70F-45A1-9B04-CB1D92BFBC6DQ35815842-7ACF2F10-241B-4F7D-84FF-F647E431A494Q35838808-7CD6AFEE-08C2-4608-A38B-9104AA3D7827Q35846494-2FE29858-D67E-4C55-9C4D-CFF8E3A0857FQ36283207-AD756F28-D283-41A1-BD3F-8BD37AE134EAQ36610373-007B4920-D93A-469C-BFFC-920AA1F7933BQ36644482-385FDEA7-4307-4936-A44F-2B5B4950ED96Q37202278-B9636F54-3221-4D97-9E77-1923B67CD908Q37586538-17284CED-00A2-4DB9-9133-C2BC41F828DCQ38078000-F833833D-452D-4D87-BFB6-5F8161DEF1E1Q38102655-C9D3CF63-3ADA-4681-850B-E32EBCB7C2E7Q38102686-B669DE06-C415-48FB-ABA9-B4926D521B08Q38196367-2B000EE3-EAA5-4C33-9E8F-3FE6B410D10DQ38206164-8D80C10C-ACE1-4786-8135-762893055BFFQ38580123-26826412-BE59-4AAC-8043-83FEEE0CBBF5Q38618048-C4A1C307-1B43-46F1-AE92-E2C34C9A4E23Q40400682-5640C707-7E26-4720-ACB5-6FEFFA9978A5Q41682361-C3EFE1DD-5286-43C7-83BC-9341CBBB7966Q42041432-E6D2E9CD-A97C-4DB9-AF60-22C2BAC3B951Q42592261-2F053214-CC78-427E-AF86-6C48D9B9354BQ46356718-B0926595-FA5C-4D10-BB5C-768648666F81Q48703799-1B817F4A-08B8-4218-AC7E-9066BC2B4652Q49160094-CEA59CFC-6377-4415-8D9A-5B11DFC9CDA3Q55174845-E9D5E6B8-F98B-4D61-B38B-D98831CD86C2Q57110813-AACBBA36-3919-4C43-ACD6-62884ED3B53FQ58572084-37BEEEB2-65A6-4017-891A-1D7C2AC00BEC
P2860
Increased expression of cystine/glutamate antiporter in multiple sclerosis
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@ast
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@en
type
label
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@ast
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@en
prefLabel
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@ast
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@en
P2860
P50
P356
P1476
Increased expression of cystine/glutamate antiporter in multiple sclerosis
@en
P2860
P2888
P356
10.1186/1742-2094-8-63
P50
P577
2011-06-03T00:00:00Z
P5875
P6179
1051114673